Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? - Porretti, S; Giavoli, C; Ronchi, C; Lombardi, G; Zaccaria, M; Valle, D; Arosio, M; Beck-Peccoz, P (J Clinical Endocrinol Metab, 2002)